slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,011 USD | -5,98% | -29,94% | -98,25% |
Grafiek agenda Invitae Corporation
Komende gebeurtenissen op Invitae Corporation
Gebeurtenissen op naam
15-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P222 |
15-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P164 |
15-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: PO32 |
15-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: PO30 |
15-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P572 |
14-03-2024 16:45 | American College of Medical Genetics and Genomics Clinical Genetics Meeting |
14-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P757 |
14-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P685 |
14-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P633 |
14-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P493 |
14-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P471 |
14-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P073 |
14-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P071 |
14-03-2024 15:30 | American College of Medical Genetics and Genomics Clinical Genetics Meeting - Poster No: P067 |
06-03-2024 13:15 | Q4 2023 Cijferpublicaties |
08-11-2023 22:30 | Q3 2023 Presentatie van de resultaten |
08-11-2023 22:01 | Q3 2023 Cijferpublicaties |
20-10-2023 17:15 | National Society of Genetic Counselors Conference - Oral Presentation C14 |
19-10-2023 23:45 | National Society of Genetic Counselors Conference - Oral No:B16 |
19-10-2023 23:45 | National Society of Genetic Counselors Conference - Oral Presentation B17 |
Geschiedenis van de jaarlijkse publicaties
Start boekjaar | december | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Omzet miljoenen USD | Gepubliceerd Verwachting Spread | 148 145 1.86% | 217 217 -0.17% | 280 278 0.49% | 460 460 0.12% | 516 515 0.28% |
EBITDA miljoenen USD | Gepubliceerd Verwachting Spread | -109 -112 2.29% | -221 -190 -16.51% | -613 -294 -108.23% | -522 -508 -2.85% | -333 -398 16.26% |
Bedrijfsresultaat (EBIT) miljoenen USD | Gepubliceerd Verwachting Spread | -123 -126 2.83% | -237 -218 -8.78% | -652 -362 -80.12% | -603 -592 -1.79% | -475 -522 8.98% |
Resultaat voor belastingen (EBT) miljoenen USD | Gepubliceerd Verwachting Spread | -132 -131 -1.15% | -260 -234 -11.13% | -714 -401 -78.08% | -416 -418 0.6% | -3 151 -3 228 2.37% |
Nettowinst (verlies) miljoenen USD | Gepubliceerd Verwachting Spread | -129 -131 0.96% | -242 -233 -3.79% | -609 -437 -39.46% | -379 -475 20.13% | -3 106 -3 189 2.58% |
WPA USD | Gepubliceerd Verwachting Spread | -1,94 -1,97 1.56% | -2,66 -2,57 -3.32% | -4,52 -3,34 -35.38% | -1,80 -2,36 23.73% | -13,2 -11,5 -14.85% |
Datum van publicatie | 19/02/19 | 19/02/20 | 17/02/21 | 24/02/22 | 28/02/23 |
Geschiedenis van de driemaandelijkse publicaties
Start boekjaar | december | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|---|
Omzet miljoenen USD | Gepubliceerd Verwachting Spread | 114 127 -9.61% | 126 126 0.18% | 124 129 -4.34% | 137 136 0.42% | 134 131 1.64% | 122 121 1.22% | 117 117 0.68% | 121 120 0.3% | 121 121 0.1% |
EBITDA miljoenen USD | Gepubliceerd Verwachting Spread | -159 -103 -54.17% | -146 -130 -12.33% | -137 -121 -13.29% | -108 -146 25.87% | -48,3 -128 62.13% | -39,7 -122 67.33% | -41,5 -74,9 44.51% | -64,0 -71,3 10.23% | -26,8 -70,0 61.75% |
Bedrijfsresultaat (EBIT) miljoenen USD | Gepubliceerd Verwachting Spread | -181 -141 -28.69% | -170 -160 -6.08% | -164 -145 -12.62% | -145 -168 13.27% | -88,8 -149 40.47% | -77,1 -134 42.39% | -76,5 -97,3 21.41% | -97,7 -86,7 -12.69% | -58,5 -86,6 32.4% |
Resultaat voor belastingen (EBT) miljoenen USD | Gepubliceerd Verwachting Spread | -204 -200 -1.81% | -213 -215 1.18% | -217 -200 -8.28% | -2 527 -211 -1097.14% | -302 -231 -30.81% | -105 -182 42.07% | -193 -144 -34.42% | -207 -118 -75.59% | -948 -127 -648.19% |
Nettowinst (verlies) miljoenen USD | Gepubliceerd Verwachting Spread | -198 -170 -16.42% | -205 -197 -4.02% | -182 -185 1.76% | -2 523 -201 -1152.92% | -301 -212 -42.15% | -99,8 -182 45.21% | -192 -132 -45.52% | -207 -116 -77.52% | -942 -124 -661.34% |
WPA USD | Gepubliceerd Verwachting Spread | -0,91 -0,82 -11.25% | -0,90 -0,89 -0.67% | -0,80 -0,83 3.32% | -10,9 -0,87 -1152.3% | -1,27 -0,84 -50.47% | -0,41 -0,79 48.23% | -0,77 -0,53 -45.74% | -0,78 -0,46 -71.43% | -3,42 -0,46 -638.13% |
Datum van publicatie | 08/11/21 | 24/02/22 | 03/05/22 | 09/08/22 | 08/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 08/11/23 |
Gebeurtenissen in het verleden in de sector Invitae Corporation
28-02-2024 22:05 | CAREDX, INC: Q4 2023 Cijferpublicaties |
28-02-2024 22:01 | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Cijferpublicaties |
22-02-2024 22:05 | VERACYTE, INC.: Q4 2023 Cijferpublicaties |
22-02-2024 22:05 | GUARDANT HEALTH, INC.: Q4 2023 Cijferpublicaties |
22-02-2024 22:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q4 2023 Cijferpublicaties |
21-02-2024 22:05 | EXACT SCIENCES CORPORATION: Q4 2023 Cijferpublicaties |
16-02-2024 | SEEGENE, INC.: Q4 2023 Cijferpublicaties |
10-11-2023 | SEEGENE, INC.: Q3 2023 Cijferpublicaties |
09-11-2023 22:05 | ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q3 2023 Cijferpublicaties |
08-11-2023 22:05 | CAREDX, INC: Q3 2023 Cijferpublicaties |
Omzet - Kwartaal - Afwijkingspercentage
Kwartaalwinst - Afwijkingspercentage
Omzet - Jaarlijks - Afwijkingspercentage
Winst van het jaar - Afwijkingspercentage
- Beurs
- Aandelen
- Aandeel Invitae Corporation - OTC Markets
- Agenda Invitae Corporation